Last reviewed · How we verify
Tonics group
At a glance
| Generic name | Tonics group |
|---|---|
| Also known as | Placepo |
| Sponsor | Assiut University |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Decreased appetite
- Pyrexia
- Fatigue
- Nasopharyngitis
- Upper respiratory tract infection
- Dizziness
- Somnolence
- Diarrhea
- Echocardiogram abnormal
- Lethargy
- Headache
- Vomiting
Key clinical trials
- A Novel Combined Neuromodulation Therapy to Enhance Balance and Neuroplasticity (NA)
- Spinal Stimulation With Gait Training to Improve Lower Limbs Motor Recovery in Spinal Cord Injury (NA)
- Senicapoc and Perampanel for Newly Diagnosed Glioblastoma (EARLY_PHASE1)
- Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (PHASE1, PHASE2)
- Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain (NA)
- Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence (NA)
- The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain (NA)
- The Clinical Research of Traditional Chinese Medicine Compound Formulas (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |